Profiel
Matthew W.
Onaitis is currently Director at Snp Bio, Inc. and Stratify Genomics, Inc., and Chief Financial Officer at Mainstay Medical International Ltd. since 2018.
Formerly, Mr. Onaitis was Director-Legal Affairs at Elan Corp.
Plc (2004-2005), Associate General Counsel at Biogen, Inc. (2006), Secretary, Senior Vice President & General Counsel at Somaxon Pharmaceuticals, Inc. (2010-2013), Secretary & General Counsel at Trius Therapeutics, Inc. (2013), Secretary & General Counsel at Ignyta, Inc. (2014-2016), and CFO, Secretary, CAO & General Counsel at Cidara Therapeutics, Inc. (2016-2018).
Education includes an undergraduate degree from Carnegie Mellon University (1993) and a graduate degree from Stanford Law School (1998).
Actieve functies van Matthew Onaitis
| Bedrijven | Functie | Begin |
|---|---|---|
| MAINSTAY MEDICAL INTERNATIONAL | Financieel Directeur/CFO | 20-08-2018 |
Snp Bio, Inc. | Directeur/Bestuurslid | - |
Stratify Genomics, Inc.
Stratify Genomics, Inc. Medical/Nursing ServicesHealth Services Operates as a cancer risk stratification company | Directeur/Bestuurslid | - |
Eerdere bekende functies van Matthew Onaitis
| Bedrijven | Functie | Einde |
|---|---|---|
| CIDARA THERAPEUTICS | Financieel Directeur/CFO | 17-08-2018 |
| IGNYTA INC | Algemeen Adviseur | 01-06-2016 |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Algemeen Adviseur | 01-12-2013 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Algemeen Adviseur | 01-03-2013 |
| BIOGEN INC. | Corporate Officer/Principal | 01-05-2006 |
Opleiding van Matthew Onaitis
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Carnegie Mellon University
Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Mainstay Medical International Ltd.
Mainstay Medical International Ltd. Medical SpecialtiesHealth Technology Develops neurostimulation therapies for people with chronic mechanical low back pain | Health Technology |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
Ignyta, Inc.
Ignyta, Inc. BiotechnologyHealth Technology Operates as a medicine biotechnology company which provides new drugs services for cancer patients | Health Technology |
Stanford Law School
Stanford Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cidara Therapeutics, Inc.
Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Snp Bio, Inc. | |
Stratify Genomics, Inc.
Stratify Genomics, Inc. Medical/Nursing ServicesHealth Services Operates as a cancer risk stratification company | Health Services |
















